BIVRX vs. UPRO
Compare and contrast key facts about Invenomic Fund (BIVRX) and ProShares UltraPro S&P 500 (UPRO).
BIVRX is managed by Invenomic. It was launched on Jun 18, 2017. UPRO is a passively managed fund by ProShares that tracks the performance of the S&P 500 Index (300%). It was launched on Jun 23, 2009.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIVRX or UPRO.
Key characteristics
| BIVRX | UPRO | |
|---|---|---|
| YTD Return | -7.30% | 24.87% |
| 1Y Return | -3.37% | 78.11% |
| 3Y Return (Ann) | 18.69% | 10.58% |
| 5Y Return (Ann) | 24.53% | 22.05% |
| Sharpe Ratio | -0.11 | 2.24 |
| Daily Std Dev | 28.36% | 34.44% |
| Max Drawdown | -25.39% | -76.82% |
| Current Drawdown | -22.80% | -10.74% |
Correlation
The correlation between BIVRX and UPRO is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BIVRX vs. UPRO - Performance Comparison
In the year-to-date period, BIVRX achieves a -7.30% return, which is significantly lower than UPRO's 24.87% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIVRX vs. UPRO - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than UPRO's 0.92% expense ratio.
Risk-Adjusted Performance
BIVRX vs. UPRO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and ProShares UltraPro S&P 500 (UPRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIVRX vs. UPRO - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 21.85%, more than UPRO's 0.65% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 21.85% | 20.26% | 28.43% | 14.52% | 3.11% | 3.21% | 4.82% | 1.21% | 0.00% | 0.00% | 0.00% | 0.00% |
UPRO ProShares UltraPro S&P 500 | 0.65% | 0.74% | 0.52% | 0.06% | 0.11% | 0.53% | 0.63% | 0.00% | 0.12% | 0.34% | 0.22% | 0.07% |
Drawdowns
BIVRX vs. UPRO - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -25.39%, smaller than the maximum UPRO drawdown of -76.82%. Use the drawdown chart below to compare losses from any high point for BIVRX and UPRO. For additional features, visit the drawdowns tool.
Volatility
BIVRX vs. UPRO - Volatility Comparison
The current volatility for Invenomic Fund (BIVRX) is 2.80%, while ProShares UltraPro S&P 500 (UPRO) has a volatility of 11.81%. This indicates that BIVRX experiences smaller price fluctuations and is considered to be less risky than UPRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.